Found 154 matching trials
Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer PHASE4 This pilot clinical trial studies how well endocrine therapy works in treat...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Study to Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer PHASE3 A study to compare the safety and efficacy of an aromatase inhibitor in com...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer PHASE1 This phase Ib trials studies the side effects and how well talimogene laher...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer PHASE4 This is a biomedical study of interventional type, multicenter, inter-regio...
Show More Learn More & Join Trial
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer PHASE2 This phase II trial tests the accuracy of functional imaging (FFNP)-positro...
Show More Location
Siteman Cancer Center at Washington University
Learn More & Join Trial
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer PHASE3 This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy PHASE3 RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Show More Location
Federico II University Medical School
Learn More & Join Trial
Study of Exemestane After Anastrozole or Letrozole Treatment of Postmenopausal Women With Hormone Responsive Breast Cancer PHASE3 The purpose of this study is to compare the rate of disease free survival (...
Show More Learn More & Join Trial